2-{[(1,3-benzothiazol-2-yl)methyl]sulfamoyl}-2-methylpropanoic acid
Structure Info
- Chemspace ID
- CSSB06327104577 (In-Stock Building Blocks)
- MFCD
- MFCD35784697
- IUPAC Name
- 2-{[(1,3-benzothiazol-2-yl)methyl]sulfamoyl}-2-methylpropanoic acid
- Mol formula
- C12H14N2O4S2
- Mol weight
- 314 Da
- Catalog Number(s)
- BBLS06327104577, BBV-494741742, EN300-52536367, bbls06327104577
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.56
- Heavy atoms count
- 20
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.333
- Polar surface area (Å)
- 96
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB06327104577
Items Overall 13 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 194.39 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 266.66 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 377.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 471.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 579.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 322.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 481.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 686.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,081.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,386.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,716.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 4,018.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 5,959.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire

![Chemical structure of tert-butyl N-[(1,3-benzothiazol-2-yl)methyl]carbamate - CSSB00011923883](/st/structure/200/1396603d3e3d7e1ca11b0545ff02e00a/CC%2528C%2529%2528C%2529OC%2528%253DO%2529NCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)methyl]ethene-1-sulfonamide - CSSB02138435757](/st/structure/200/356ceccbbf1c3a1f041754b16461d125/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)methyl]acetamide - CSSB00000154331](/st/structure/200/983d3aca6de237069fd369358d98e3f3/CC%2528%253DO%2529NCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of 2-[(1,3-benzothiazol-2-yl)methyl]-2-ethylbutanoic acid - CSSB00000627241](/st/structure/200/87485bf652bb0b7c00d2a80962afb31a/CCC%2528CC%2529%2528CC1%253DNC2%253DCC%253DCC%253DC2S1%2529C%2528O%2529%253DO.png)
![Chemical structure of 2-[(2-fluorophenyl)sulfamoyl]-2-methylpropanoic acid - CSSB06270845576](/st/structure/200/4e0dbcb7c03d8ded6869158799a26ed9/CC%2528C%2529%2528C%2528%253DO%2529O%2529S%2528%253DO%2529%2528%253DO%2529Nc1ccccc1F.png)
![Chemical structure of 1-[(1,3-benzothiazol-2-yl)methyl]cyclopentane-1-carboxylic acid - CSSB00000602572](/st/structure/200/a74d4c1f4f29fe36acb718536e18d0a4/OC%2528%253DO%2529C1%2528CC2%253DNC3%253DCC%253DCC%253DC3S2%2529CCCC1.png)
